Navigation Links
Breast Cancer Drug Might Treat Bipolar Disorder
Date:3/3/2008

Tamoxifen may ease condition's mania phase, but side effects could be a problem, experts say

MONDAY, March 3 (HealthDay News) -- A drug commonly used to treat breast cancer may one day help manage symptoms of mania, or the "high" phase experienced by people with bipolar disorder, researchers say.

Men and women who took tamoxifen for three weeks experienced a significant lessening of their mania compared to people taking a placebo, the study found.

Whether or not tamoxifen will become a mainstay of treatment for bipolar disorder remains to be seen, however.

"The bad news is [that] this is something we would have to figure out how side effects are going to be a factor in long-term use," said one expert, Dr. Jane Ripperger-Suhler, assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine and a psychiatrist with Scott & White Mental Health Center. "The good news is that people are thinking outside the box in terms of what might be effective for a particular disorder."

"More trials need to be conducted," added Dr. Ma-Li Wong, professor of psychiatry and vice chair for translational research at the University of Miami Miller School of Medicine. "Tamoxifen is not a drug that is without side effects. One needs to be careful in terms of drawing conclusions. Bipolar is not a short-term disorder and in clinical trials for breast cancer, you're talking about treatment of five years. Also, the dose used in this study is a bit high in comparison to that used in breast cancer."

The findings, by researchers at Dokuz Eylül University Medical School in Izmir, Turkey, are published in the March issue of Archives of General Psychiatry.

Tamoxifen helps suppress breast cancer by interfering with the action of the female hormone estrogen in the body.

The drug also inhibits the activity of a family of enzymes known as protein
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. New study of targeted therapies for breast cancer -- model for global clinical trials
2. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
3. Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells
4. Breast cancer death rates among black women not decreasing across all states
5. Breast cancer subtypes linked to survival from secondary brain tumors
6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
7. Representative Greg Harris, Senator Jacqueline Collins, Senator Iris Martinez and Fellow State Legislators to Join Susan G. Komen for the Cure in Announcing Groundbreaking Legislation to Reduce Breast Cancer Disparities; Will Hold Press Conference Friday
8. Cost of Breast Cancer Can Include Paycheck
9. Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
10. Hormone therapy increases frequency of abnormal mammograms, breast biopsies
11. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Drug Might Treat Bipolar Disorder
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... 2015 Dr. Mark Sowell recently returned from ... AZ. Offering programs for advanced education in the field of ... , As a visiting faculty member of this prestigious ... each time he visits Spear Education to participate in a ... “we are training only the top 10% and those willing ...
(Date:3/5/2015)... 2015 From Oct. 5-10, Mumbai, India will ... Conference . These dates include the following activities:, ... , October 6: Conference Day 1, ending with ... Conference Day 2, ending with Local Entertainment and Dinner , ... and other Materials Meetings , October 9-10: Textiles ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2
... As part of a Research and Development partnership ... joins Halo Pharmaceutical as Chief Scientific Officer. Halo and ... the development of several client products. "I am excited ... and the opportunity to work closely together with a ...
... Care Accessible to EveryoneCARLSBAD, Calif., April 20 Today,s woman ... kids, managing a career and household, and may even be ... deserves a break and, even in these tough times, she ... image possible."In a time like this, it,s more important than ...
... Health Survey Shows Physician Visits Are First to Go When ... are postponing healthcare due to cost, according to a study ... A total of 20 percent of U.S. households postponed or ... 2006. Among those who postponed or cancelled care, 24.1 ...
... website that lets cash-paying patients shop and compare prices ... With an estimated 700,000 people without health ... insurance, finding affordable healthcare can ... have health insurance find that vision, dentistry, cosmetic, or ...
... St. Louis, April 20, 2009 The search for ... aggressive childhood lung cancer has uncovered important information about ... the development of other cancers. , The finding ... St. Louis, Children,s National Medical Center in Washington, D.C., ...
... the edge off, manage intakeNEW ORLEANS, April 20 ... Redenbacher,s 94 percent fat-free SmartPop! popcorn, before a meal ... calorie intake, says a new study released today.Guided by ... Rippe Lifestyle Institute, the study found that subjects who ...
Cached Medicine News:Health News:Halo Pharmaceutical Welcomes Dr. George Bobotas as Its Chief Scientific Officer 2Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 2Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 3Health News:Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost 2Health News:Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost 3Health News:New Website Helps Families Find Better Healthcare at a Better Price 2Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 2Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 3Health News:Squeezing Calories? New Study Finds That Low-Fat Popcorn Before Lunch Does Not Increase Total Calorie Intake 2
(Date:3/5/2015)... Corporation (Nasdaq: IRIX ) today reported financial results ... , Revenues were $11.8 million in the fourth ... 11% from $10.6 million in the 2013 fourth quarter. Revenues ... from $38.3 million in 2013. , Gross margin for ... the fourth quarter of the prior year. , Operating ...
(Date:3/5/2015)... TUSTIN, Calif. , March 5, 2015  BioPhotas, ... energy products that use patented photo-therapeutic technologies to treat ... has partnered with the Semper Fi Fund to provide ... members in need of pain management solutions.  ... reported, "The first Marine who used the Celluma at ...
(Date:3/5/2015)... 5, 2015   ndd Medical Technologies , a ... employs precise ultrasound technology, announced that its EasyOne Pro® ... the San Antonio Pulmonary Fibrosis Support Group. The clinic ... fibrosis (PF), as well as those suspected of having ... a mere 12 square inches, EasyOne Pro provides accurate ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... JERUSALEM, Israel, June 15 ,The University of Pittsburgh ... announced today that the Institute has joined an elite,group of ... are now,enrolling patients to participate in the ExCell research study. ... assessing the safety and efficacy of StemEx(R), an,investigational product derived ...
... , IRVINE, Calif., June 12 Masimo (Nasdaq: ... Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that ... utility of Masimo PVI as a noninvasive and continuous ... this week at the European Society of Anaesthesiology (ESA) ...
Cached Medicine Technology:UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients 2UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6